000 | 01571 a2200433 4500 | ||
---|---|---|---|
005 | 20250515015647.0 | ||
264 | 0 | _c20061024 | |
008 | 200610s 0 0 eng d | ||
022 | _a0012-186X | ||
024 | 7 |
_a10.1007/s00125-006-0161-3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGarg, S | |
245 | 0 | 0 |
_aEfficacy and safety of preprandial human insulin inhalation powder versus injectable insulin in patients with type 1 diabetes. _h[electronic resource] |
260 |
_bDiabetologia _cMay 2006 |
||
300 |
_a891-9 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Inhalation |
650 | 0 | 4 |
_aBlood Glucose _xdrug effects |
650 | 0 | 4 | _aCross-Over Studies |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xblood |
650 | 0 | 4 | _aDiet, Diabetic |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aEating |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
650 | 0 | 4 | _aInjections, Subcutaneous |
650 | 0 | 4 |
_aInsulin _xadministration & dosage |
650 | 0 | 4 | _aInsulin Lispro |
650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
650 | 0 | 4 | _aSafety |
700 | 1 | _aRosenstock, J | |
700 | 1 | _aSilverman, B L | |
700 | 1 | _aSun, B | |
700 | 1 | _aKonkoy, C S | |
700 | 1 | _ade la Peña, A | |
700 | 1 | _aMuchmore, D B | |
773 | 0 |
_tDiabetologia _gvol. 49 _gno. 5 _gp. 891-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00125-006-0161-3 _zAvailable from publisher's website |
999 |
_c16116579 _d16116579 |